Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Jan 25, 2022 3:12pm
264 Views
Post# 34359301

RE:RE:RE:RE:RE:Aristotle testing volumes and daily schedule

RE:RE:RE:RE:RE:Aristotle testing volumes and daily schedule
molotov420 wrote: Oh Gojo....how about for you we ballpark it at about 30M by year end and we'll ask Tripp to finally announce the large employer too. 

Lith your numbers seem realistic but who knows what's going on with those consultations. Could be anything, even someone just removing appointments. We need quarterly reports to tell us whats really happening. 


Here is gojotv's prediction from 19 aug 2021:

If you don't think this stock is an easy double from HERE...

Then you just don't understand math.
From here, easy double in four months, and tripled by Christmas.
Q3 financials will point to where SZLS is going, for those who can read the signs.
Meanwhile, Q2 revenues were over six (6) times Q2 2020 revenues.
Anyone who doesn't see the growth story here shouldn't be investing with their own money. 
Maybe they can take up a life of stock bashing like our resident multi-aliased loser.
That cheap-hearted stock thief... What a fulfilling life he leads. *eyeroll.
Pay attention, do your DD...
and...
SINAI GROUP

Here is what actually happened to SZLS:

August 19, 2021 - 03:16 PM  szls = $.040

Easy double would be $0.80 by 19 Dec 2021, triple would be $1.20 by Xmas

Actual szls price at xmas $0.29, current price price $0.235


GOJOTV is a blowhard with absolutely no credibility, he has no shame whatsoever and keeps posting his inane rants. He has NEVER been even close let alone correct.
CHEERS.
p.s. I understand math, just not gojotv's version. The boards are littered with 10 years of his ramblings. Oh yeah if you really want to get a look inside his head google gojo anime.
<< Previous
Bullboard Posts
Next >>